Ms. Gleason is a senior partner with the law firm of Morgan Lewis in Washington, D.C., where she manages the FDA/Healthcare Regulation Practice Group, covering the full spectrum of issues (from premarket development to postmarket compliance) for biological, pharma, and medical device entities. For small and mid-cap life sciences companies, Ms. Gleason and her attorneys and regulatory scientists specialize in all aspects of pipeline/pathway strategy development. She received her J.D. from Georgetown University and her B.A. from Johns Hopkins University, where she was elected to Phi Beta Kappa.